This volume of the Handbook of Neurochemistry and Molecular Neurobiology focuses on neurochemical aspects of schizophrenia. Chapters cover the full range of schizophrenia symptoms and anatomical pathologies from neurochemical and molecular biology perspectives. Topics include changes in neurotransmitter systems, alteration in receptors, neurotransmitter release, genetic factors, protein alterations, and redox dysregulation.
This volume of the Handbook of Neurochemistry and Molecular Neurobiology focuses on neurochemical aspects of schizophrenia. Chapters cover the full range of schizophrenia symptoms and anatomical pathologies from neurochemical and molecular biology perspectives. Topics include changes in neurotransmitter systems, alteration in receptors, neurotransmitter release, genetic factors, protein alterations, and redox dysregulation.
Artikelnr. des Verlages: 11531043, 978-0-387-30365-9
3. Aufl.
Seitenzahl: 564
Erscheinungstermin: 22. September 2009
Englisch
Abmessung: 248mm x 170mm x 39mm
Gewicht: 1077g
ISBN-13: 9780387303659
ISBN-10: 0387303650
Artikelnr.: 26435732
Inhaltsangabe
Hippocampus.- Redox dysregulation in schizophrenia: Genetic susceptibility and pathophysiological mechanisms.- An overview and current perspective on family studies of schizophrenia.- Synaptic vesicle associated proteins and schizophrenia.- Cortical dopamine in schizophrenia.- G72/g30 in neuropsychiatric disorders.- Cholinergic mechanisms in schizophrenia.- The neurobiology of negative symptoms and the deficit syndrome.- Alterations of neurotransmitter receptors in schizophrenia: Evidence from postmortem studies.- Auditory cortex anatomy and asymmetry in schizophrenia.- Event related potentials (ERPS) in the study of schizophrenia: How pre-clinical ERP studies have contributed to our understanding of schizophrenia.- Neuregulin 1 and schizophrenia.- The role of prefrontal abnormalities in schizophrenia.- Early-stage visual processing deficits in schizophrenia and implications for higher level function.- Magnetic resonance spectroscopy.- Dysbindin-1 and its protein family.- Glutamate and schizophrenia: Phencyclidine, n-methyl-d-aspartate (NMDA) receptors: Etiology and treatment.
Hippocampus.- Redox dysregulation in schizophrenia: Genetic susceptibility and pathophysiological mechanisms.- An overview and current perspective on family studies of schizophrenia.- Synaptic vesicle associated proteins and schizophrenia.- Cortical dopamine in schizophrenia.- G72/g30 in neuropsychiatric disorders.- Cholinergic mechanisms in schizophrenia.- The neurobiology of negative symptoms and the deficit syndrome.- Alterations of neurotransmitter receptors in schizophrenia: Evidence from postmortem studies.- Auditory cortex anatomy and asymmetry in schizophrenia.- Event related potentials (ERPS) in the study of schizophrenia: How pre-clinical ERP studies have contributed to our understanding of schizophrenia.- Neuregulin 1 and schizophrenia.- The role of prefrontal abnormalities in schizophrenia.- Early-stage visual processing deficits in schizophrenia and implications for higher level function.- Magnetic resonance spectroscopy.- Dysbindin-1 and its protein family.- Glutamate and schizophrenia: Phencyclidine, n-methyl-d-aspartate (NMDA) receptors: Etiology and treatment.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497